Clobazam Tablets, 20 mg, CIV, 100-count bottle, Rx only, Manufactured by Centaur Pharmaceuticals Pvt. Ltd., Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037, NDC 51991-901-01
Published March 22, 2023 · Recall initiated: March 2, 2023
Summary
FDA records drug Class II recall D-0463-2023, published March 22, 2023 and initiated March 2, 2023. Recalling firm: Breckenridge Pharmaceutical, Inc; Status: Terminated; Reported quantity: N/A; Lot: Lot # 5210147, Exp 12/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Potential risk of Cross Contamination
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Breckenridge Pharmaceutical, Inc
- Distributor
- USA nationwide.
- Lot
- Lot # 5210147, Exp 12/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADuloxetine Delayed-Release Capsules USP, 60 mg, 1000-count bottles, Rx Only, Manufactured by TowaApril 30, 2025
- FDADuloxetine Delayed-Release Capsules USP, 30 mg, a.) 90-count bottles (NDC# 51991-747-90), b.) 1000-countApril 30, 2025
- FDADuloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 90-count bottles (NDC 51991-747-90) Mfr. by: TowaJanuary 1, 2025
- FDADuloxetine Delayed-Release Capsules, USP, 60 mg, Rx Only, 90-count bottles (NDC 51991-748-90) Mfr. by: TowaJanuary 1, 2025
- FDAClobazam Tablets, 10 mg, CIV, 100-count bottle, Rx only, Manufactured by Centaur Pharmaceuticals Pvt. Ltd.,March 22, 2023
- FDAEvamist (estradiol transdermal spray), 1.53 mg of estradiol per spray, 0.27 fl oz (8.1 mL) per metered-doseMarch 22, 2023
Questions about this recall
Was Clobazam Tablets, 20 mg, CIV, 100-count bottle, Rx only, Manufactured by Centaur Pharmaceuticals Pvt. Ltd., Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037, NDC 51991-901-01 recalled?
Yes. FDA published recall D-0463-2023 on March 22, 2023. Reported hazard: CGMP Deviations: Potential risk of Cross Contamination
What should I do if I have this product?
Voluntary: Firm initiated · Letter